PTC THERAPEUTICS, INC. (PTCT)


Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading PTC THERAPEUTICS, INC. chart...

About the Company

PTC Therapeutics is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

1467

Exchange

Nasdaq

$35M

Total Revenue

1K

Employees

$2B

Market Capitalization

-3.07

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $PTCT News

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

1d ago, source:

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on April 19, 2024, the company approved non-statutory stock options to purchase an aggregate of 8,090 shares of its common stock and 8,290 ...

PTC Therapeutics Inc PTCT

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ATTENTION PTC Therapeutics, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights

1mon ago, source: WATE 6 On Your Side

NEW YORK, NY / ACCESSWIRE / March 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of PTC Therapeutics, Inc. ("PTC") (NASDAQ:PTCT) concerning possible ...

PTC Therapeutics gets grant for treatment of huntington’s disease using compound of formula (IBBL)

3d ago, source: Pharmaceutical Technology

Discover the latest patent from PTC Therapeutics Inc for treating Huntington's disease with innovative compounds and pharmaceutical compositions. Learn more about the groundbreaking Formula (I) and ...

PTC Therapeutics, Inc.: PTC Therapeutics Provides Key Regulatory Updates

1mon ago, source: Finanznachrichten

About PTC Therapeutics, Inc. PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to ...

PTC Therapeutics Inc

2d ago, source: U.S. News & World Report

What's the difference between mutual funds and stocks? For starters, they suit different investing styles.

PTCT PTC Therapeutics, Inc.

1mon ago, source: Seeking Alpha

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders in the United States and internationally.

PTCT PTC Therapeutics, Inc.

8d ago, source: Seeking Alpha

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders in the United States and internationally.

PTC Therapeutics Inc PTCT

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

PTC Therapeutics Inc.

28d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...